Treatment of Massive Pulmonary Thromboembolism with Low Intrapulmonary Dosages of Urokinase

This publication has 13 references indexed in Scilit:

• RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISM
  The Lancet, 1988
• The UKEP study: Multicentre clinical trial on two local regimens of urokinase in massive pulmonary embolism
  European Heart Journal, 1987
• Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial.
  Circulation, 1984
• Thrombolytic Therapy in Thrombosis: A National Institutes of Health Consensus Development Conference
  Annals of Internal Medicine, 1980
• The Use of Thrombolytic Agents: Choice of Patient, Drug Administration, Laboratory Monitoring
  Annals of Internal Medicine, 1979
• Plasminogen and Moderate Doses of Urokinase in the Treatment of Acute Pulmonary Embolism
  Angiology, 1979
• Thrombolysis with a Combination of Small Doses of Streptokinase and Full Doses of Heparin
  Seminars in Thrombosis and Hemostasis, 1975
• Urokinase-Streptokinase Embolism Trial
  JAMA, 1974
• Comparison of Streptokinase and Heparin in Treatment of Isolated Acute Massive Pulmonary Embolism
  BMJ, 1971
• Urokinase Pulmonary Embolism Trial
  JAMA, 1970